 | • レポートコード：QFJ1-5085 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、アルテミシニン併用療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アルテメテル＋ルメファントリン、アルテスネート＋アモジアキン、ジヒドロアルテミシニン＋ピペラキン、アルテスネート＋メフロキン、アルテスネート＋スルファドキシン-ピリメタミン、ピロナリジン-アルテスネート、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・アルテミシニン併用療法の市場動向 ・企業の競争状況、市場シェア ・アルテミシニン併用療法の種類別市場規模と予測2016-2027（アルテメテル＋ルメファントリン、アルテスネート＋アモジアキン、ジヒドロアルテミシニン＋ピペラキン、アルテスネート＋メフロキン、アルテスネート＋スルファドキシン-ピリメタミン、ピロナリジン-アルテスネート、その他） ・アルテミシニン併用療法の用途別市場規模と予測2016-2027（病院、診療所、その他） ・アルテミシニン併用療法の北米市場規模2016-2027（アメリカ、カナダ） ・アルテミシニン併用療法の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・アルテミシニン併用療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・アルテミシニン併用療法の中南米市場規模2016-2027（メキシコ、ブラジル） ・アルテミシニン併用療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（KPC Pharmaceuticals、Shanghai Fosun Pharmaceutical Industrial Development、Sanofi、Desano Holdings、Calyx Chemicals and Pharmaceuticals、Mylan、Novartis、Denk Pharma、Hovid Berhad、Ipca Laboratories、Cipla、Aspen Pharmacare Holdings、Ajanta Pharma、Guilin Pharmaceuticals） ・結論 |
Artemisinin Combination Therapy is recommended for thetreatment of P. falciparum malaria. Fast acting artemisinin-based compounds arecombined with a drug from a different class and artemisinin derivatives include dihydroartemisinin, artesunate and artemether.
Market Analysis and Insights: Global Artemisinin Combination Therapy Market
The global Artemisinin Combination Therapy market size is projected to reach US$ 498.6 million by 2027, from US$ 347.9 million in 2020, at a CAGR of 4.8% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Artemisinin Combination Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Artemisinin Combination Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Artemisinin Combination Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Artemisinin Combination Therapy market.
Global Artemisinin Combination Therapy Scope and Market Size
Artemisinin Combination Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Artemisinin Combination Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Artemether+Lumefantrine
Artesunate+Amodiaquine
Dihydroartemisinin+Piperaquine
Artesunate+Mefloquine
Artesunate+Sulfadoxine-Pyrimethamine
Pyronaridine-Artesunate
Other
Segment by Application
Hospital
Clinic
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
KPC Pharmaceuticals
Shanghai Fosun Pharmaceutical Industrial Development
Sanofi
Desano Holdings
Calyx Chemicals and Pharmaceuticals
Mylan
Novartis
Denk Pharma
Hovid Berhad
Ipca Laboratories
Cipla
Aspen Pharmacare Holdings
Ajanta Pharma
Guilin Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artemisinin Combination Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Artemether+Lumefantrine
1.2.3 Artesunate+Amodiaquine
1.2.4 Dihydroartemisinin+Piperaquine
1.2.5 Artesunate+Mefloquine
1.2.6 Artesunate+Sulfadoxine-Pyrimethamine
1.2.7 Pyronaridine-Artesunate
1.2.8 Other
1.3 Market by Application
1.3.1 Global Artemisinin Combination Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Artemisinin Combination Therapy Market Perspective (2016-2027)
2.2 Artemisinin Combination Therapy Growth Trends by Regions
2.2.1 Artemisinin Combination Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Artemisinin Combination Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Artemisinin Combination Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Artemisinin Combination Therapy Industry Dynamic
2.3.1 Artemisinin Combination Therapy Market Trends
2.3.2 Artemisinin Combination Therapy Market Drivers
2.3.3 Artemisinin Combination Therapy Market Challenges
2.3.4 Artemisinin Combination Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artemisinin Combination Therapy Players by Revenue
3.1.1 Global Top Artemisinin Combination Therapy Players by Revenue (2016-2021)
3.1.2 Global Artemisinin Combination Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Artemisinin Combination Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Artemisinin Combination Therapy Revenue
3.4 Global Artemisinin Combination Therapy Market Concentration Ratio
3.4.1 Global Artemisinin Combination Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artemisinin Combination Therapy Revenue in 2020
3.5 Artemisinin Combination Therapy Key Players Head office and Area Served
3.6 Key Players Artemisinin Combination Therapy Product Solution and Service
3.7 Date of Enter into Artemisinin Combination Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artemisinin Combination Therapy Breakdown Data by Type
4.1 Global Artemisinin Combination Therapy Historic Market Size by Type (2016-2021)
4.2 Global Artemisinin Combination Therapy Forecasted Market Size by Type (2022-2027)
5 Artemisinin Combination Therapy Breakdown Data by Application
5.1 Global Artemisinin Combination Therapy Historic Market Size by Application (2016-2021)
5.2 Global Artemisinin Combination Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Artemisinin Combination Therapy Market Size (2016-2027)
6.2 North America Artemisinin Combination Therapy Market Size by Type
6.2.1 North America Artemisinin Combination Therapy Market Size by Type (2016-2021)
6.2.2 North America Artemisinin Combination Therapy Market Size by Type (2022-2027)
6.2.3 North America Artemisinin Combination Therapy Market Size by Type (2016-2027)
6.3 North America Artemisinin Combination Therapy Market Size by Application
6.3.1 North America Artemisinin Combination Therapy Market Size by Application (2016-2021)
6.3.2 North America Artemisinin Combination Therapy Market Size by Application (2022-2027)
6.3.3 North America Artemisinin Combination Therapy Market Size by Application (2016-2027)
6.4 North America Artemisinin Combination Therapy Market Size by Country
6.4.1 North America Artemisinin Combination Therapy Market Size by Country (2016-2021)
6.4.2 North America Artemisinin Combination Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Artemisinin Combination Therapy Market Size (2016-2027)
7.2 Europe Artemisinin Combination Therapy Market Size by Type
7.2.1 Europe Artemisinin Combination Therapy Market Size by Type (2016-2021)
7.2.2 Europe Artemisinin Combination Therapy Market Size by Type (2022-2027)
7.2.3 Europe Artemisinin Combination Therapy Market Size by Type (2016-2027)
7.3 Europe Artemisinin Combination Therapy Market Size by Application
7.3.1 Europe Artemisinin Combination Therapy Market Size by Application (2016-2021)
7.3.2 Europe Artemisinin Combination Therapy Market Size by Application (2022-2027)
7.3.3 Europe Artemisinin Combination Therapy Market Size by Application (2016-2027)
7.4 Europe Artemisinin Combination Therapy Market Size by Country
7.4.1 Europe Artemisinin Combination Therapy Market Size by Country (2016-2021)
7.4.2 Europe Artemisinin Combination Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Artemisinin Combination Therapy Market Size (2016-2027)
8.2 Asia-Pacific Artemisinin Combination Therapy Market Size by Type
8.2.1 Asia-Pacific Artemisinin Combination Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Artemisinin Combination Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Artemisinin Combination Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Artemisinin Combination Therapy Market Size by Application
8.3.1 Asia-Pacific Artemisinin Combination Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Artemisinin Combination Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Artemisinin Combination Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Artemisinin Combination Therapy Market Size by Region
8.4.1 Asia-Pacific Artemisinin Combination Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Artemisinin Combination Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Artemisinin Combination Therapy Market Size (2016-2027)
9.2 Latin America Artemisinin Combination Therapy Market Size by Type
9.2.1 Latin America Artemisinin Combination Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Artemisinin Combination Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Artemisinin Combination Therapy Market Size by Type (2016-2027)
9.3 Latin America Artemisinin Combination Therapy Market Size by Application
9.3.1 Latin America Artemisinin Combination Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Artemisinin Combination Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Artemisinin Combination Therapy Market Size by Application (2016-2027)
9.4 Latin America Artemisinin Combination Therapy Market Size by Country
9.4.1 Latin America Artemisinin Combination Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Artemisinin Combination Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artemisinin Combination Therapy Market Size (2016-2027)
10.2 Middle East & Africa Artemisinin Combination Therapy Market Size by Type
10.2.1 Middle East & Africa Artemisinin Combination Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Artemisinin Combination Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Artemisinin Combination Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Artemisinin Combination Therapy Market Size by Application
10.3.1 Middle East & Africa Artemisinin Combination Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Artemisinin Combination Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Artemisinin Combination Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Artemisinin Combination Therapy Market Size by Country
10.4.1 Middle East & Africa Artemisinin Combination Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Artemisinin Combination Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 KPC Pharmaceuticals
11.1.1 KPC Pharmaceuticals Company Details
11.1.2 KPC Pharmaceuticals Business Overview
11.1.3 KPC Pharmaceuticals Artemisinin Combination Therapy Introduction
11.1.4 KPC Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2016-2021)
11.1.5 KPC Pharmaceuticals Recent Development
11.2 Shanghai Fosun Pharmaceutical Industrial Development
11.2.1 Shanghai Fosun Pharmaceutical Industrial Development Company Details
11.2.2 Shanghai Fosun Pharmaceutical Industrial Development Business Overview
11.2.3 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Introduction
11.2.4 Shanghai Fosun Pharmaceutical Industrial Development Revenue in Artemisinin Combination Therapy Business (2016-2021)
11.2.5 Shanghai Fosun Pharmaceutical Industrial Development Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Artemisinin Combination Therapy Introduction
11.3.4 Sanofi Revenue in Artemisinin Combination Therapy Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Desano Holdings
11.4.1 Desano Holdings Company Details
11.4.2 Desano Holdings Business Overview
11.4.3 Desano Holdings Artemisinin Combination Therapy Introduction
11.4.4 Desano Holdings Revenue in Artemisinin Combination Therapy Business (2016-2021)
11.4.5 Desano Holdings Recent Development
11.5 Calyx Chemicals and Pharmaceuticals
11.5.1 Calyx Chemicals and Pharmaceuticals Company Details
11.5.2 Calyx Chemicals and Pharmaceuticals Business Overview
11.5.3 Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Introduction
11.5.4 Calyx Chemicals and Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2016-2021)
11.5.5 Calyx Chemicals and Pharmaceuticals Recent Development
11.6 Mylan
11.6.1 Mylan Company Details
11.6.2 Mylan Business Overview
11.6.3 Mylan Artemisinin Combination Therapy Introduction
11.6.4 Mylan Revenue in Artemisinin Combination Therapy Business (2016-2021)
11.6.5 Mylan Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Artemisinin Combination Therapy Introduction
11.7.4 Novartis Revenue in Artemisinin Combination Therapy Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 Denk Pharma
11.8.1 Denk Pharma Company Details
11.8.2 Denk Pharma Business Overview
11.8.3 Denk Pharma Artemisinin Combination Therapy Introduction
11.8.4 Denk Pharma Revenue in Artemisinin Combination Therapy Business (2016-2021)
11.8.5 Denk Pharma Recent Development
11.9 Hovid Berhad
11.9.1 Hovid Berhad Company Details
11.9.2 Hovid Berhad Business Overview
11.9.3 Hovid Berhad Artemisinin Combination Therapy Introduction
11.9.4 Hovid Berhad Revenue in Artemisinin Combination Therapy Business (2016-2021)
11.9.5 Hovid Berhad Recent Development
11.10 Ipca Laboratories
11.10.1 Ipca Laboratories Company Details
11.10.2 Ipca Laboratories Business Overview
11.10.3 Ipca Laboratories Artemisinin Combination Therapy Introduction
11.10.4 Ipca Laboratories Revenue in Artemisinin Combination Therapy Business (2016-2021)
11.10.5 Ipca Laboratories Recent Development
11.11 Cipla
11.11.1 Cipla Company Details
11.11.2 Cipla Business Overview
11.11.3 Cipla Artemisinin Combination Therapy Introduction
11.11.4 Cipla Revenue in Artemisinin Combination Therapy Business (2016-2021)
11.11.5 Cipla Recent Development
11.12 Aspen Pharmacare Holdings
11.12.1 Aspen Pharmacare Holdings Company Details
11.12.2 Aspen Pharmacare Holdings Business Overview
11.12.3 Aspen Pharmacare Holdings Artemisinin Combination Therapy Introduction
11.12.4 Aspen Pharmacare Holdings Revenue in Artemisinin Combination Therapy Business (2016-2021)
11.12.5 Aspen Pharmacare Holdings Recent Development
11.13 Ajanta Pharma
11.13.1 Ajanta Pharma Company Details
11.13.2 Ajanta Pharma Business Overview
11.13.3 Ajanta Pharma Artemisinin Combination Therapy Introduction
11.13.4 Ajanta Pharma Revenue in Artemisinin Combination Therapy Business (2016-2021)
11.13.5 Ajanta Pharma Recent Development
11.14 Guilin Pharmaceuticals
11.14.1 Guilin Pharmaceuticals Company Details
11.14.2 Guilin Pharmaceuticals Business Overview
11.14.3 Guilin Pharmaceuticals Artemisinin Combination Therapy Introduction
11.14.4 Guilin Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2016-2021)
11.14.5 Guilin Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Artemisinin Combination Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Artemether+Lumefantrine
Table 3. Key Players of Artesunate+Amodiaquine
Table 4. Key Players of Dihydroartemisinin+Piperaquine
Table 5. Key Players of Artesunate+Mefloquine
Table 6. Key Players of Artesunate+Sulfadoxine-Pyrimethamine
Table 7. Key Players of Pyronaridine-Artesunate
Table 8. Key Players of Other
Table 9. Global Artemisinin Combination Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Artemisinin Combination Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Artemisinin Combination Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Artemisinin Combination Therapy Market Share by Regions (2016-2021)
Table 13. Global Artemisinin Combination Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Artemisinin Combination Therapy Market Share by Regions (2022-2027)
Table 15. Artemisinin Combination Therapy Market Trends
Table 16. Artemisinin Combination Therapy Market Drivers
Table 17. Artemisinin Combination Therapy Market Challenges
Table 18. Artemisinin Combination Therapy Market Restraints
Table 19. Global Artemisinin Combination Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Artemisinin Combination Therapy Market Share by Players (2016-2021)
Table 21. Global Top Artemisinin Combination Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artemisinin Combination Therapy as of 2020)
Table 22. Ranking of Global Top Artemisinin Combination Therapy Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Artemisinin Combination Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Artemisinin Combination Therapy Product Solution and Service
Table 26. Date of Enter into Artemisinin Combination Therapy Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Artemisinin Combination Therapy Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Artemisinin Combination Therapy Revenue Market Share by Type (2016-2021)
Table 30. Global Artemisinin Combination Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Artemisinin Combination Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Artemisinin Combination Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Artemisinin Combination Therapy Revenue Market Share by Application (2016-2021)
Table 34. Global Artemisinin Combination Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Artemisinin Combination Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Artemisinin Combination Therapy Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Artemisinin Combination Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Artemisinin Combination Therapy Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Artemisinin Combination Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Artemisinin Combination Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Artemisinin Combination Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Artemisinin Combination Therapy Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Artemisinin Combination Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Artemisinin Combination Therapy Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Artemisinin Combination Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Artemisinin Combination Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Artemisinin Combination Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Artemisinin Combination Therapy Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Artemisinin Combination Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Artemisinin Combination Therapy Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Artemisinin Combination Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Artemisinin Combination Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Artemisinin Combination Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Artemisinin Combination Therapy Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Artemisinin Combination Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Artemisinin Combination Therapy Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Artemisinin Combination Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Artemisinin Combination Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Artemisinin Combination Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Artemisinin Combination Therapy Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Artemisinin Combination Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Artemisinin Combination Therapy Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Artemisinin Combination Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Artemisinin Combination Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Artemisinin Combination Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 66. KPC Pharmaceuticals Company Details
Table 67. KPC Pharmaceuticals Business Overview
Table 68. KPC Pharmaceuticals Artemisinin Combination Therapy Product
Table 69. KPC Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2016-2021) & (US$ Million)
Table 70. KPC Pharmaceuticals Recent Development
Table 71. Shanghai Fosun Pharmaceutical Industrial Development Company Details
Table 72. Shanghai Fosun Pharmaceutical Industrial Development Business Overview
Table 73. Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Product
Table 74. Shanghai Fosun Pharmaceutical Industrial Development Revenue in Artemisinin Combination Therapy Business (2016-2021) & (US$ Million)
Table 75. Shanghai Fosun Pharmaceutical Industrial Development Recent Development
Table 76. Sanofi Company Details
Table 77. Sanofi Business Overview
Table 78. Sanofi Artemisinin Combination Therapy Product
Table 79. Sanofi Revenue in Artemisinin Combination Therapy Business (2016-2021) & (US$ Million)
Table 80. Sanofi Recent Development
Table 81. Desano Holdings Company Details
Table 82. Desano Holdings Business Overview
Table 83. Desano Holdings Artemisinin Combination Therapy Product
Table 84. Desano Holdings Revenue in Artemisinin Combination Therapy Business (2016-2021) & (US$ Million)
Table 85. Desano Holdings Recent Development
Table 86. Calyx Chemicals and Pharmaceuticals Company Details
Table 87. Calyx Chemicals and Pharmaceuticals Business Overview
Table 88. Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Product
Table 89. Calyx Chemicals and Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2016-2021) & (US$ Million)
Table 90. Calyx Chemicals and Pharmaceuticals Recent Development
Table 91. Mylan Company Details
Table 92. Mylan Business Overview
Table 93. Mylan Artemisinin Combination Therapy Product
Table 94. Mylan Revenue in Artemisinin Combination Therapy Business (2016-2021) & (US$ Million)
Table 95. Mylan Recent Development
Table 96. Novartis Company Details
Table 97. Novartis Business Overview
Table 98. Novartis Artemisinin Combination Therapy Product
Table 99. Novartis Revenue in Artemisinin Combination Therapy Business (2016-2021) & (US$ Million)
Table 100. Novartis Recent Development
Table 101. Denk Pharma Company Details
Table 102. Denk Pharma Business Overview
Table 103. Denk Pharma Revenue in Artemisinin Combination Therapy Business (2016-2021) & (US$ Million)
Table 104. Denk Pharma Recent Development
Table 105. Hovid Berhad Company Details
Table 106. Hovid Berhad Business Overview
Table 107. Hovid Berhad Artemisinin Combination Therapy Product
Table 108. Hovid Berhad Revenue in Artemisinin Combination Therapy Business (2016-2021) & (US$ Million)
Table 109. Hovid Berhad Recent Development
Table 110. Ipca Laboratories Company Details
Table 111. Ipca Laboratories Business Overview
Table 112. Ipca Laboratories Artemisinin Combination Therapy Product
Table 113. Ipca Laboratories Revenue in Artemisinin Combination Therapy Business (2016-2021) & (US$ Million)
Table 114. Ipca Laboratories Recent Development
Table 115. Cipla Company Details
Table 116. Cipla Business Overview
Table 117. Cipla Artemisinin Combination Therapy Product
Table 118. Cipla Revenue in Artemisinin Combination Therapy Business (2016-2021) & (US$ Million)
Table 119. Cipla Recent Development
Table 120. Aspen Pharmacare Holdings Company Details
Table 121. Aspen Pharmacare Holdings Business Overview
Table 122. Aspen Pharmacare Holdings Artemisinin Combination Therapy Product
Table 123. Aspen Pharmacare Holdings Revenue in Artemisinin Combination Therapy Business (2016-2021) & (US$ Million)
Table 124. Aspen Pharmacare Holdings Recent Development
Table 125. Ajanta Pharma Company Details
Table 126. Ajanta Pharma Business Overview
Table 127. Ajanta Pharma Artemisinin Combination Therapy Product
Table 128. Ajanta Pharma Revenue in Artemisinin Combination Therapy Business (2016-2021) & (US$ Million)
Table 129. Ajanta Pharma Recent Development
Table 130. Guilin Pharmaceuticals Company Details
Table 131. Guilin Pharmaceuticals Business Overview
Table 132. Guilin Pharmaceuticals Artemisinin Combination Therapy Product
Table 133. Guilin Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2016-2021) & (US$ Million)
Table 134. Guilin Pharmaceuticals Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Artemisinin Combination Therapy Market Share by Type: 2020 VS 2027
Figure 2. Artemether+Lumefantrine Features
Figure 3. Artesunate+Amodiaquine Features
Figure 4. Dihydroartemisinin+Piperaquine Features
Figure 5. Artesunate+Mefloquine Features
Figure 6. Artesunate+Sulfadoxine-Pyrimethamine Features
Figure 7. Pyronaridine-Artesunate Features
Figure 8. Other Features
Figure 9. Global Artemisinin Combination Therapy Market Share by Application: 2020 VS 2027
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Other Case Studies
Figure 13. Artemisinin Combination Therapy Report Years Considered
Figure 14. Global Artemisinin Combination Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Artemisinin Combination Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Artemisinin Combination Therapy Market Share by Regions: 2020 VS 2027
Figure 17. Global Artemisinin Combination Therapy Market Share by Regions (2022-2027)
Figure 18. Global Artemisinin Combination Therapy Market Share by Players in 2020
Figure 19. Global Top Artemisinin Combination Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artemisinin Combination Therapy as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Artemisinin Combination Therapy Revenue in 2020
Figure 21. Global Artemisinin Combination Therapy Revenue Market Share by Type (2016-2021)
Figure 22. Global Artemisinin Combination Therapy Revenue Market Share by Type (2022-2027)
Figure 23. North America Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Artemisinin Combination Therapy Market Share by Type (2016-2027)
Figure 25. North America Artemisinin Combination Therapy Market Share by Application (2016-2027)
Figure 26. North America Artemisinin Combination Therapy Market Share by Country (2016-2027)
Figure 27. United States Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Artemisinin Combination Therapy Market Share by Type (2016-2027)
Figure 31. Europe Artemisinin Combination Therapy Market Share by Application (2016-2027)
Figure 32. Europe Artemisinin Combination Therapy Market Share by Country (2016-2027)
Figure 33. Germany Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Artemisinin Combination Therapy Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Artemisinin Combination Therapy Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Artemisinin Combination Therapy Market Share by Region (2016-2027)
Figure 43. China Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Artemisinin Combination Therapy Market Share by Type (2016-2027)
Figure 51. Latin America Artemisinin Combination Therapy Market Share by Application (2016-2027)
Figure 52. Latin America Artemisinin Combination Therapy Market Share by Country (2016-2027)
Figure 53. Mexico Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Artemisinin Combination Therapy Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Artemisinin Combination Therapy Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Artemisinin Combination Therapy Market Share by Country (2016-2027)
Figure 59. Turkey Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Artemisinin Combination Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. KPC Pharmaceuticals Revenue Growth Rate in Artemisinin Combination Therapy Business (2016-2021)
Figure 63. Shanghai Fosun Pharmaceutical Industrial Development Revenue Growth Rate in Artemisinin Combination Therapy Business (2016-2021)
Figure 64. Sanofi Revenue Growth Rate in Artemisinin Combination Therapy Business (2016-2021)
Figure 65. Desano Holdings Revenue Growth Rate in Artemisinin Combination Therapy Business (2016-2021)
Figure 66. Calyx Chemicals and Pharmaceuticals Revenue Growth Rate in Artemisinin Combination Therapy Business (2016-2021)
Figure 67. Mylan Revenue Growth Rate in Artemisinin Combination Therapy Business (2016-2021)
Figure 68. Novartis Revenue Growth Rate in Artemisinin Combination Therapy Business (2016-2021)
Figure 69. Denk Pharma Revenue Growth Rate in Artemisinin Combination Therapy Business (2016-2021)
Figure 70. Hovid Berhad Revenue Growth Rate in Artemisinin Combination Therapy Business (2016-2021)
Figure 71. Ipca Laboratories Revenue Growth Rate in Artemisinin Combination Therapy Business (2016-2021)
Figure 72. Cipla Revenue Growth Rate in Artemisinin Combination Therapy Business (2016-2021)
Figure 73. Aspen Pharmacare Holdings Revenue Growth Rate in Artemisinin Combination Therapy Business (2016-2021)
Figure 74. Ajanta Pharma Revenue Growth Rate in Artemisinin Combination Therapy Business (2016-2021)
Figure 75. Guilin Pharmaceuticals Revenue Growth Rate in Artemisinin Combination Therapy Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
世界のアルテスネイト薬市場規模・現状・予測（2021年-2027年） Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quinidine for severe malaria. Often it is used as part of combination therapy. It is not used for the prevention of malaria. Market Analysis and Insights: Global Artesunate Medicines Market The global Artesun…- 世界のアルテスネイト薬剤市場規模・現状・予測（2021年-2027年） Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quinidine for severe malaria. Often it is used as part of combination therapy. It is not used for the prevention of malaria. Market Analysis and Insights: Global Artesunate Drugs Market The global Artesunate …
- アルテスネイト錠剤のグローバル市場2021 Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quinidine for severe malaria. Often it is used as part of combination therapy. It is not used for the prevention of malaria. The classification of Artesunate Tablet includes Monoaromatic Artesunate and Compou…
- アーテスネートのグローバル市場調査 2019年 The global Artesunate market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Artesunate volume and value at global level, regional level and company level. From a global perspective, this report represents…
- アルテミシニンのグローバル市場2021 Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now a…